Coppus A, Evenhuis H, Verberne G-J, Visser F, van Gool P, Eikelenboom P, van Duijin C
Department of Epidemiology & Biostatistics, Erasmus MC, Rotterdam, the Netherlands.
J Intellect Disabil Res. 2006 Oct;50(Pt 10):768-77. doi: 10.1111/j.1365-2788.2006.00842.x.
Numerous studies have documented that persons with Down's syndrome (DS) are at an increased risk of Alzheimer's disease (AD). However, at present it is still not clear whether or not all persons with DS will develop dementia as they reach old age.
We studied 506 people with DS, aged 45 years and above. A standardized assessment of cognitive, functional and physical status was repeated annually. If deterioration occurred, the patients were examined and the differential diagnosis of dementia was made according to the revised Dutch consensus protocol and according to the ICD-10 Symptom Checklist for Mental Disorders. We compared our findings with those reported in the literature.
The overall prevalence of dementia was 16.8%. Up to the age of 60, the prevalence of dementia doubled with each 5-year interval. Up to the age of 49, the prevalence is 8.9%, from 50 to 54, it is 17.7%, and from 55 to 59, it is 32.1%. In the age category of 60 and above, there is a small decrease in prevalence of dementia to 25.6%. The lack of increase after the age of 60 may be explained by the increased mortality among elderly demented DS patients (44.4%) in comparison with non-demented patients (10.7%) who we observed during a 3.3-year follow-up. There was no decrease in incidence of dementia in the age group of 60 and above. Our findings are very similar to those published in the literature. Patients with dementia were more frequently treated with antiepileptic, antipsychotic and antidepressant drugs. The history of depression was strongly associated with dementia.
Our study is one of the largest population-based studies to date. We found that despite the exponential increase in prevalence with age, the prevalence of dementia in the oldest persons with DS was not higher than 25.6%.
大量研究表明,唐氏综合征(DS)患者患阿尔茨海默病(AD)的风险增加。然而,目前尚不清楚是否所有DS患者在老年时都会发展为痴呆症。
我们研究了506名年龄在45岁及以上的DS患者。每年对认知、功能和身体状况进行标准化评估。如果出现恶化情况,则对患者进行检查,并根据修订后的荷兰共识协议和国际疾病分类第10版精神障碍症状清单进行痴呆症的鉴别诊断。我们将研究结果与文献报道进行了比较。
痴呆症的总体患病率为16.8%。在60岁之前,痴呆症的患病率每5年翻一番。在49岁之前,患病率为8.9%,50至54岁为17.7%,55至59岁为32.1%。在60岁及以上年龄组,痴呆症患病率略有下降,降至25.6%。60岁以后患病率没有增加,可能是因为在3.3年的随访中,我们观察到老年痴呆DS患者的死亡率(44.4%)高于非痴呆患者(10.7%)。60岁及以上年龄组的痴呆症发病率没有下降。我们的研究结果与文献报道非常相似。痴呆患者更常使用抗癫痫药、抗精神病药和抗抑郁药进行治疗。抑郁症病史与痴呆症密切相关。
我们的研究是迄今为止最大的基于人群的研究之一。我们发现,尽管患病率随年龄呈指数增长,但最年长的DS患者的痴呆症患病率不高于25.6%。